Launch of the Initial Public Offering

September 17, 2018

MedinCell launches its initial public offering on the regulated market of Euronext in Paris
• Capital increase of approximately €34.1m, which may be increased to a maximum of approximately €45.1m if the extension clause and the over-allotment option are fully exercised1
• Indicative Offering Price range: €7.25 to €9.25 per share
• Closing of Open Price Offering: September 26, 2018 (at 5.00 pm (CEST) for subscriptions placed at counters and 8.00 pm (CEST time) for online subscriptions)
• Closing of the Global Placement: September 27, 2018 (at 12.00 pm (CEST time))
• Settlement-delivery of the Offering: October 1st, 2018
• Beginning of trading of the MedinCell shares: October 2nd 2018
• Eligibility to PEA-PME
• Strong support from institutional investors to the operation: subscription commitments from CM-CIC Innovation up to €4.7m and BNP Paribas Développement of €3m

1 Based on the median point of the indicative price range

Session en français

Rendez-vous le mardi 12 septembre à 18h00 pour la diffusion en direct de l'Assemblée Générale mixte

English session

On Tuesday September 12 at 6:00 p.m. live of the Combined General Meeting (in French)

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.


  • This field is for validation purposes and should be left unchanged.